2026 / 03

DOI: 10.24075/brsmu.2026.038
Copyright: © 2026 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

The effect of diclofenac sodium on bone marrow cellularity, the LSK cell pool, and cytokine profiles in mice with experimental dermatitis

Bondorenko DV1,3 , Ivanov AS1,2,3 , Tananakina TP3 , Kashchenko SA3 , Pogorelova IA3 , Alexandrov IA1
About authors

1 MEDSI Clinic, Clinical Hospital No. 1, Moscow, Russia

2 Polyclinic on Smolenskaya Scientific and Diagnostic Center, Moscow, Russia

3 Saint Luka LSMU, Russia

Correspondence should be addressed: Alexey S. Ivanov
A. Dikogo, 16A, kv. 73, 111396, Moscow; ur.liam@5891golotamvartahsas

About paper

Acknowledgements: The authors express their sincere gratitude to S. Gramatyuk and M. Noebauer (UAB Global) for methodological support and significant contribution to the design, planning, and conceptualization of this experimental research.

Author contribution: Bondorenko DV, Ivanov AS — study design, experimental part of the work; Tananakina TP — study design, experimental part of the work, scientific support; Kashchenko SA — scientific text editing, scientific support, experiment preparation; Pogorelova IA — text editing, experiment preparation, animal care consultations, drug dose calculations; Alexandrov IA — animal care, experimental part of the work.

Compliance with ethical standards: the study was approved by the Ethics Committee of St. Luka LSMU, Ministry of Health of the Russian Federation (Minutes No. 1 of January 27, 2026), conducted in accordance with the Recommendations of the Board of the Eurasian Economic Commission of November 14, 2023 No. 33 "Guidelines for working with laboratory (experimental) animals during preclinical (non-clinical) studies," in compliance with the principles of the European Convention for the Protection of Vertebrates used for Experimental and Other Scientific Purposes, as well as in accordance with the Directive of the

Received: 2026-05-15 Accepted: 2026-06-16 Published online: 2026-06-30
|
  1. Bagmut IYu, Ivanov OS, Sheremet MI, Smirnov SM, Kolisnyk IL, Ivanova JV, et al. Isolation of megakaryocytes using magnetic cell separation and adverse effects induced by diclofenac toxicity in an experiment. J Med Life. 2022; 15 (1): 65–70. DOI: 10.25122/jml-2020-0129.
  2. Ivanov О, Haidash O, Voloshin V, Kondratov S, Smirnov A. Influence of the acting substance sodium diclofenac on bone marrow cells. Georgian Medical News. 2020; 306: 137–42. PMID: 33130661.
  3. Ivanov AS, Tananakina TP, Kashchenko SA, Pogorelova IA. Expression of microRNA miR146a in the blood plasma of rats with obesity and knee arthrosis after administration of dexamethasone. Bulletin of RSMU. 2025; 6: 209–15. DOI: 10.24075/brsmu.2025.056.
  4. Ivanov OS, Vasylenko OV. Effect of diclofenac sodium on granulocytic cells of the bone marrow of laboratory mice. Sciences of Europe. 2020; 52–2: 14–20. Available from: https://cyberleninka. ru/article/n/vpliv-diklofenaku-natriyu-na-klitini-granulotsitarno-ryadu-kistkovogo-mozku-laboratornih-mishey (дата обращения: 21.03.2026).
  5. Bagmut IYu, Ivanov OS, Erofeeva VV, Abramova TV, Kion OI, Ermolash TA, et al. Effect of the active substance diclofenac sodium on bone marrow cells. Sciences of Europe. 2020; 53–2 (53): 13–19. Available from: https://cyberleninka.ru/article/n/ effect-of-the-active-substance-diclofenac-sodium-on-bone-marrow-cells (дата обращения: 21.03.2026).
  6. Bemidinezhad A, Zojaji SA, Jamshidi ST, Mohammadi M, Alavi MS, Ghorbani A. Evaluation of acute, subacute, and subchronic toxicity of a hepatoprotective herbal formulation. Toxicol Rep. 2023; 11: 452– 459. Available from: https://doi. org/10.1016/j.toxrep.2023.11.002.
  7. Hadi WH, Abood AH, Imarah AAS. Histopathological changes affected by oral administration of diclofenac sodium in the bone marrow of male albino rats (Rattus rattus). Punjab Univ J Zool. 2025; 41 (1): 63–69. Available from: https://dx.doi.org/10.17582/ journal.pujz/2025/41.1.63.69.
  8. Aboubakr M, Abdelkader A, Habotta OA, Adel N, Emam MA, Abdelhiee EY, et al. Cefepime and diclofenac sodium combined treatment–potentiated multiple organ injury: Role of oxidative damage and disrupted lipid metabolism. J Biochem Mol Toxicol. 2021; 35: e22929. Available from: https://doi.org/10.1002/jbt.22929.
  9. Ahire D, Heyward S, Prasad B. Intestinal metabolism of diclofenac by polymorphic UGT2B17 correlates with its highly variable pharmacokinetics and safety across populations. Clin Pharmacol Therapeut. 2023; 114: 161–72. Available from: https://doi.org/10.1002/ cpt.2907.
  10. Minardi ML, Fato I, Di Gennaro F, Mosti S, Mastrobattista A, Cerva C, et al. Common and rare hematological manifestations and adverse drug events during treatment of active TB: A state of art. Microorganisms. 2021; 9: 1477. Available from: https:// doi.org/10.3390/microorganisms9071477.
  11. Nedospasov SA. Cytokines — regulators of immunity. Bulletin of Moscow University. Series 16. Biology. 2024; 79 (2S): 16–21. DOI: 10.55959/MSU0137-0952-16-79-2S-3. Russian.
  12. Potekaev NN, Tereshchenko GP, Zhukova OV, Gadzhigoroeva AG, Khanferyan RA. Comparative evaluation of cytokine profiles in pediatric alopecia areata patients considering concomitant atopic diseases: An observational cohort cross-sectional study. Kuban Scientific Medical Bulletin. 2025; 32 (4): 82–95. Available from: https://doi.org/10.25207/1608-6228-2025-32-4-82-95. Russian.
  13. Nasonov EL, Samsonov MYu. The role of interleukin 1 in the development of human diseases: focus on anakinra (IL1 receptor antagonist). Scientific and Practical Rheumatology. 2022; 60 (3): 280–98. DOI: 10.47360/1995-4484-2022-280-298. Russian.
  14. Tereshchenko IV, Kayushev PE. Tumor necrosis factor α and its role in pathology. RMJ. Medical Review. 2022; 6 (9): 523–27. DOI: 10.32364/2587-6821-2022-6-9-523-527. Russian.
  15. Topolyanskaya SV. Tumor necrosis factor alpha and age-associated pathology. Archive of Internal Medicine. 2020; 10 (6): 414–21 DOI: 10.20514/2226-6704-2020-10-6-414-421. Russian.
  16. Alexeeva EI, Tepaev RF, Shilkrot IY, Dvoryakovskaya TM, Surkov AG, Kriulin IA. COVID-19-Induced “Cytokine Storm” — a Unique Form of Macrophage Activation Syndrome. Annals of the Russian Academy of Medical Sciences. 2021; 76 (1): 51–66. Available from: https://doi.org/10.15690/vramn1410. Russian.
  17. Chen X-Y, Yan B-X, Man X-Y. TNFα Inhibitor may be effective for severe COVID-19: learning from toxic epidermal Necrolysis. Ther Adv Respir Dis. 2020; 14: 1753466620926800. DOI: 10.1177/1753466620926800.
  18. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71 (15): 762–8. DOI: 10.1093/cid/ciaa248.
  19. Fara A, Mitrev Z, Rosalia RA, Assas BM. Cytokine Storm and COVID-19: a Chronicle of proinflammatory Cytokines. Open Biol. 2020; 10 (9): 200160. DOI: 10.1098/rsob.200160.
  20. Axmedjanova N.I. Significance of cytokine profile in renal complications in children during the COVID-19 pandemic: An observational cohort retrospective clinical study. Kuban Scientific Medical Bulletin. 2025; 32 (1): 29–38. Available from: https://doi. org/10.25207/1608-6228-2025-32-1-29-38. Russian.
  21. Li P, Zheng Y, Chen X. Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics. Front Pharmacol. 2017; 8: 460. DOI: 10.3389/fphar.2017.00460.
  22. Zhao Y, Zhang H, Li N, Li J, Zhang L. Chronic Pain after Bone Fracture: Current Insights into Molecular Mechanisms and Therapeutic Strategies. Brain Sciences. 2022; 12 (8): 1056. Available from: https://doi.org/10.3390/brainsci12081056..
  23. European Convention for the Protection of Vertebrate Animals Used for Experiments or Other Scientific Purposes. 18.03.1986. Strasbourg, 1986; 13 pp.
  24. Directive No. 2010/63/eu of the European Parliament and of the Council on the protection of animals used for scientific purposes (complies with the requirements of the European Economic Area). 01.01.2013. Strasbourg, 2010. 48 pp. Russian.
  25. Ivanova JuV, Gramatiuk SM, Kryvoruchko IA, Prasol VO, Pulyaeva IS, Miasoiedov КV, et al. The Effect of pulsed photobiomodulation on proliferation and migration of human mesenchymal stem cells in vitro. Clinical and preventive medicine. 2024; (5): 87–92. Available from: https://doi.org/10.31612/2616-4868.5.2024.11.
  26. Gramatiuk SM, Ivanova YuV, Hudyma AA, Sargsyan K, Kryvoruchko IA, Puliaieva IS. Differentiation of neurosphere after transplantation into the damaged spinal cord. J Med and Life. 2023; 16 (5): 689–98. DOI: 10.25122/jml-2022-0346.
  27. Muhammad Zeeshan Rana. ‘NSAIDs Effect on Bone Healing’. Innovation in Osteogenesis Research, IntechOpen, 18 June 2024. Crossref. DOI: 10.5772/intechopen.1005088.
  28. Juliana Oluwafunmilayo Ajayi, Emmanuel Bukoye Oyewo, Adeniran Sanmi Adekunle, Peace Temidayo Ige, Peter Ayomide Akomolafe. Subchronic doses of artemether-lumefantrine, ciprofloxacin and diclofenac precipitated inflammatory and immunological dysfunctions in female Wistar rats. Cytokine. 2024; 176: 156515. Available from: https://doi.org/10.1016/j.cyto.2024.156515.
  29. Gramatiuk S, Kryvoruchko I, Ivanova Y, Hubbard E, Noebauer- Babenko M, Sargsyan K. Artificial Intelligence-Based Quality Control of Cell Lines. Biopreserv Biobank. 2025. DOI: 10.1177/19475535251367317.